Cargando…
Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers
Although loss of functional β-cell mass is a hallmark of diabetes, no treatment approaches that halt this process are currently available. We recently identified thioredoxin-interacting protein (TXNIP) as an attractive target in this regard. Glucose and diabetes upregulate β-cell TXNIP expression, a...
Autores principales: | Xu, Guanlan, Chen, Junqin, Jing, Gu, Shalev, Anath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314354/ https://www.ncbi.nlm.nih.gov/pubmed/22442301 http://dx.doi.org/10.2337/db11-0955 |
Ejemplares similares
-
Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop
por: Jing, Gu, et al.
Publicado: (2016) -
Regulation of Calcium-Permeable TRPV2 Channel by Insulin in Pancreatic β-Cells
por: Hisanaga, Etsuko, et al.
Publicado: (2009) -
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204
por: Xu, Guanlan, et al.
Publicado: (2013) -
Loss of HGF/c-Met Signaling in Pancreatic β-Cells Leads to Incomplete Maternal β-Cell Adaptation and Gestational Diabetes Mellitus
por: Demirci, Cem, et al.
Publicado: (2012) -
Inhibition of β-Cell Sodium-Calcium Exchange Enhances Glucose-Dependent Elevations in Cytoplasmic Calcium and Insulin Secretion
por: Hamming, Kevin S.C., et al.
Publicado: (2010)